LINC00906

Across TCGA pan-cancer cohorts, LINC00906 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC00906’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC00906 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00906 is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

KIRC, BRCA, and LUSC are the cancer types where LINC00906 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00906 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.277	<.001	7	view →
BRCA	Female	II,III,IV	−0.087	<.001	6	view →
LUSC	All	All	−0.060	<.001	6	view →
LIHC	All	All	+0.161	.006	5	view →
ESCA	All	All	−0.188	.035	1	view →
KIRP	All	All	+0.176	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC00906–KIRC

Open the KIRC breakdown →